Farrell, David J. PhD*; Klugman, Keith P. MD†; Pichichero, Michael MD‡
From the *G. R. Micro Ltd, London, U.K.; †Hubert Department of Global Health, Rollins School of Public Health and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA; and the ‡University of Rochester, Rochester, NY.
Accepted for publication November 6, 2006.
Dr. Farrell has been a consultant to sanofi-aventis and Pfizer and has received funding from sanofi-aventis, Pfizer, Theravance and Bayer. Dr. Pichichero has received honoraria for speaking and consulting, and has received research grants from sanofi-aventis. Dr. Klugman has been a consultant to sanofi-aventis and Bayer and has received research support from sanofi-aventis.
Address for correspondence: David J. Farrell, PhD, G. R. Micro Ltd., 7–9 William Road, London NW1 3ER, U.K. E-mail: [email protected].